Thoracic retransplantation : Does time to retransplantation matter?
Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved..
OBJECTIVE: For some individuals, chronic allograft failure is best treated with retransplantation. We sought to determine if time to retransplantation impacts short- and long-term outcomes for heart or lung retransplant recipients with a time to retransplantation more than 1 year.
METHODS: The United Network for Organ Sharing/Organ Procurement and Transplantation Network STAR file was queried for all adult, first-time heart (June 1, 2006, to September 30, 2020) and lung (May 1, 2005, to September 30, 2020) retransplantations with a time to retransplantation of at least 1 year. Patients were grouped according to the tertile of time to retransplantation (tertile 1: 1-7.7 years, tertile 2: 7.7-14.7 years, tertile 3: 14.7+ years; lung: tertile 1: 1-2.8 years, tertile 2: 2.8-5.6 years, tertile 3: 5.6+ years). The primary outcome was survival after retransplantation. Comparative statistics identified differences in groups, and Kaplan-Meier methods and a Cox proportional hazard model were used for survival analysis.
RESULTS: After selection, 908 heart and 871 lung retransplants were identified. Among heart retransplant recipients, tertile 1 was associated with male sex, smoking history, higher listing status, and increased mechanical support pretransplant. Tertile 3 had the highest rate of concomitant kidney transplant; however, the incidence of morbidity and in-hospital mortality was similar among the groups. Unadjusted and adjusted analyses revealed no survival difference among all groups. Regarding lung retransplant recipients, tertile 1 was associated with increased lung allocation score, pretransplant hospitalization, and mechanical support. Unadjusted and adjusted survival analyses revealed decreased survival in tertile 1.
CONCLUSIONS: Time to retransplant does not appear to affect heart recipients with a time to retransplantation of more than 1 year; however, shorter time to retransplantation for prior lung recipients is associated with decreased survival. Potential lung retransplant candidates with a time to retransplantation of less than 2.8 years should be carefully evaluated before retransplantation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:166 |
---|---|
Enthalten in: |
The Journal of thoracic and cardiovascular surgery - 166(2023), 6 vom: 14. Dez., Seite 1529-1541.e4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ganapathi, Asvin M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Heart transplant |
---|
Anmerkungen: |
Date Completed 14.11.2023 Date Revised 22.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jtcvs.2022.05.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345672429 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345672429 | ||
003 | DE-627 | ||
005 | 20231226025615.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jtcvs.2022.05.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1152.xml |
035 | |a (DE-627)NLM345672429 | ||
035 | |a (NLM)36049964 | ||
035 | |a (PII)S0022-5223(22)00527-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ganapathi, Asvin M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Thoracic retransplantation |b Does time to retransplantation matter? |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.11.2023 | ||
500 | |a Date Revised 22.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVE: For some individuals, chronic allograft failure is best treated with retransplantation. We sought to determine if time to retransplantation impacts short- and long-term outcomes for heart or lung retransplant recipients with a time to retransplantation more than 1 year | ||
520 | |a METHODS: The United Network for Organ Sharing/Organ Procurement and Transplantation Network STAR file was queried for all adult, first-time heart (June 1, 2006, to September 30, 2020) and lung (May 1, 2005, to September 30, 2020) retransplantations with a time to retransplantation of at least 1 year. Patients were grouped according to the tertile of time to retransplantation (tertile 1: 1-7.7 years, tertile 2: 7.7-14.7 years, tertile 3: 14.7+ years; lung: tertile 1: 1-2.8 years, tertile 2: 2.8-5.6 years, tertile 3: 5.6+ years). The primary outcome was survival after retransplantation. Comparative statistics identified differences in groups, and Kaplan-Meier methods and a Cox proportional hazard model were used for survival analysis | ||
520 | |a RESULTS: After selection, 908 heart and 871 lung retransplants were identified. Among heart retransplant recipients, tertile 1 was associated with male sex, smoking history, higher listing status, and increased mechanical support pretransplant. Tertile 3 had the highest rate of concomitant kidney transplant; however, the incidence of morbidity and in-hospital mortality was similar among the groups. Unadjusted and adjusted analyses revealed no survival difference among all groups. Regarding lung retransplant recipients, tertile 1 was associated with increased lung allocation score, pretransplant hospitalization, and mechanical support. Unadjusted and adjusted survival analyses revealed decreased survival in tertile 1 | ||
520 | |a CONCLUSIONS: Time to retransplant does not appear to affect heart recipients with a time to retransplantation of more than 1 year; however, shorter time to retransplantation for prior lung recipients is associated with decreased survival. Potential lung retransplant candidates with a time to retransplantation of less than 2.8 years should be carefully evaluated before retransplantation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a heart transplant | |
650 | 4 | |a lung transplant | |
650 | 4 | |a retransplantation | |
650 | 4 | |a transplant outcomes | |
700 | 1 | |a Heh, Victor |e verfasserin |4 aut | |
700 | 1 | |a Rosenheck, Justin P |e verfasserin |4 aut | |
700 | 1 | |a Keller, Brian C |e verfasserin |4 aut | |
700 | 1 | |a Mokadam, Nahush A |e verfasserin |4 aut | |
700 | 1 | |a Lampert, Brent C |e verfasserin |4 aut | |
700 | 1 | |a Whitson, Bryan A |e verfasserin |4 aut | |
700 | 1 | |a Henn, Matthew C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of thoracic and cardiovascular surgery |d 1959 |g 166(2023), 6 vom: 14. Dez., Seite 1529-1541.e4 |w (DE-627)NLM000033510 |x 1097-685X |7 nnns |
773 | 1 | 8 | |g volume:166 |g year:2023 |g number:6 |g day:14 |g month:12 |g pages:1529-1541.e4 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtcvs.2022.05.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 166 |j 2023 |e 6 |b 14 |c 12 |h 1529-1541.e4 |